- Home
- SAGE vs UIS Comparison
SAGE vs UIS Comparison
Compare SAGE & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- UIS
- Stock Information
- Founded
- SAGE 2010
- UIS 1942
- Country
- SAGE United States
- UIS United States
- Employees
- SAGE N/A
- UIS N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- UIS EDP Services
- Sector
- SAGE Health Care
- UIS Technology
- Exchange
- SAGE Nasdaq
- UIS Nasdaq
- Market Cap
- SAGE 462.2M
- UIS 474.3M
- IPO Year
- SAGE 2014
- UIS N/A
- Fundamental
- Price
- SAGE $5.00
- UIS $7.70
- Analyst Decision
- SAGE Hold
- UIS
- Analyst Count
- SAGE 20
- UIS 0
- Target Price
- SAGE $12.89
- UIS N/A
- AVG Volume (30 Days)
- SAGE 854.9K
- UIS 890.9K
- Earning Date
- SAGE 10-29-2024
- UIS 10-29-2024
- Dividend Yield
- SAGE N/A
- UIS N/A
- EPS Growth
- SAGE N/A
- UIS N/A
- EPS
- SAGE N/A
- UIS N/A
- Revenue
- SAGE $106,399,000.00
- UIS $2,020,600,000.00
- Revenue This Year
- SAGE N/A
- UIS $0.92
- Revenue Next Year
- SAGE $118.26
- UIS $2.90
- P/E Ratio
- SAGE N/A
- UIS N/A
- Revenue Growth
- SAGE 837.60
- UIS 0.29
- 52 Week Low
- SAGE $4.62
- UIS $3.32
- 52 Week High
- SAGE $28.26
- UIS $8.49
- Technical
- Relative Strength Index (RSI)
- SAGE 32.20
- UIS 57.11
- Support Level
- SAGE $4.62
- UIS $7.13
- Resistance Level
- SAGE $5.87
- UIS $8.42
- Average True Range (ATR)
- SAGE 0.39
- UIS 0.35
- MACD
- SAGE -0.10
- UIS -0.08
- Stochastic Oscillator
- SAGE 21.18
- UIS 30.88
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.